Topical drug delivery platform for upper gi tract diseases
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
43
NCT04849390
A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 29, 2021
Completion: Oct 9, 2023
Loading map...